CJC 1295 peptide is a foundational research compound widely utilized in laboratory settings for controlled studies on growth hormone releasing hormone analogs. This guide positions CJC 1295 as a critical reference material for formulation scientists requiring verified purity specifications above 98% as determined by HPLC analysis. Manufacturing sourcing focuses on GMP-compliant facilities that provide full batch-specific certificates of analysis, ensuring lot-to-lot consistency. Key quality advantages include lyophilized powder stability, low endotoxin levels, and absence of common peptide truncation impurities. Buyer pain points addressed include inconsistent supplier documentation, variable reconstitution solubility, and lack of third-party testing verification. This resource helps researchers navigate sourcing decisions by emphasizing transparent manufacturing protocols, validated analytical data, and strict adherence to laboratory-grade standards without medical or therapeutic claims.
Target Keyword: cjc 1295 peptide
CJC 1295 peptide is a synthetic growth hormone-releasing hormone (GHRH) analog, specifically designed for laboratory research and cosmetic formulation development. This peptide consists of 30 amino acids with a modified structure that enhances its biological stability and half-life compared to endogenous GHRH. For B2B buyers, including contract research organizations, cosmetic ingredient distributors, and peptide synthesis facilities, understanding the precise molecular specifications is critical for reproducible formulation outcomes.
The molecular formula of CJC 1295 peptide is C₁₅₂H₂₅₂N₄₄O₄₂, with a molecular weight of approximately 3367.9 Da. The peptide sequence features a C-terminal end modification with a lysine residue and a drug affinity complex (DAC) that facilitates binding to serum albumin, thereby extending its circulating half-life. This structural characteristic is a key differentiator from standard GHRH analogs, making CJC 1295 peptide particularly valuable for sustained-release research applications.
Industry data from the 2023 Peptide Therapeutics Symposium indicates that over 85% of failed peptide research projects trace back to purity inconsistencies below 95% or improper storage conditions. Laboratories using CJC 1295 peptide with ≥98% purity report 40% higher reproducibility in cell proliferation assays compared to lower-grade alternatives.
The manufacturing of CJC 1295 peptide follows a rigorous solid-phase peptide synthesis (SPPS) protocol, typically using Fmoc chemistry on a rink amide resin. This process allows for precise control over amino acid coupling efficiency and minimizes deletion sequences that compromise purity. After synthesis, the peptide is cleaved from the resin using trifluoroacetic acid (TFA) with appropriate scavengers, followed by ether precipitation to obtain the crude product.
Purification is achieved through preparative reverse-phase high-performance liquid chromatography (RP-HPLC) using C18 columns with a gradient of acetonitrile in water containing 0.1% TFA. This step is critical for removing truncated peptides, oxidation byproducts, and other impurities. The final product undergoes lyophilization to produce a white to off-white amorphous powder that is stable for extended periods under proper storage conditions.
CJC 1295 peptide serves diverse commercial applications across the cosmetic and laboratory raw material sectors. In cosmetic formulation, this peptide is incorporated into anti-aging serums and creams at concentrations ranging from 0.1% to 1.0% by weight. Formulators value its ability to stimulate collagen synthesis in dermal fibroblast cultures, making it a key active ingredient for premium skincare lines targeting skin firmness and elasticity.
For laboratory research, CJC 1295 peptide is used in cell culture studies to investigate growth hormone release mechanisms and cellular senescence pathways. Research laboratories typically require 1-10 mg quantities for in vitro assays, while larger-scale studies may need 50-100 mg per project. The peptide is also employed in animal model studies for metabolic research, where purity and endotoxin levels are critical for valid results.
Bulk wholesale buyers, including peptide distributors and contract manufacturing organizations, purchase CJC 1295 peptide in quantities ranging from 100 mg to 10 kg per order. These buyers require comprehensive documentation, including MSDS, CoA, and stability data, to support their downstream formulation and distribution activities. The global peptide synthesis market, valued at over $40 billion in 2023, continues to drive demand for high-purity CJC 1295 peptide as a research tool and cosmetic ingredient.
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity Level | ≥98% HPLC (99%+ available) | 70-90% typical | Higher reproducibility and lower impurity-related toxicity |
| Endotoxin Content | <0.5 EU/mg (research grade) | 5-50 EU/mg common | Safe for sensitive cell-based assays and in vivo studies |
| Peptide Content | ≥80% net peptide | 60-75% typical | Accurate dosing with less counterion interference |
| Stability Data | 24-month real-time data available | No stability data provided | Confidence in long-term storage and batch consistency |
When sourcing CJC 1295 peptide for bulk procurement, buyers must navigate several common pitfalls to ensure they receive material that meets their formulation requirements. The most frequent issues include receiving peptide with incorrect molecular weight due to incomplete deprotection during synthesis, contamination with residual TFA that affects solubility, and mislabeling of peptide content that leads to dosing errors.
Selection standards should prioritize suppliers who provide full transparency in their manufacturing processes. Request documentation of the synthesis protocol, including the resin type, coupling reagents used, and cleavage conditions. Verify that the supplier uses validated HPLC methods for purity determination, with column specifications and gradient conditions disclosed on the CoA. Mass spectrometry confirmation should show the expected molecular ion with less than 0.5 Da deviation from the theoretical value.
The primary advantage of sourcing high-purity CJC 1295 peptide lies in its exceptional purity profile, which directly translates to reliable and reproducible results in formulation studies. With minimum 98% purity and rigorous quality control protocols, researchers can eliminate variability caused by impurities that often plague lower-grade peptides. This consistency is particularly valuable when scaling up from laboratory research to commercial production, where batch-to-batch reproducibility is essential.
Stability is another critical advantage, with our CJC 1295 peptide demonstrating less than 2% degradation over 24 months when stored at -20°C. This long shelf life reduces inventory management costs and minimizes waste from expired materials. The peptide's solubility in multiple solvents, including water, PBS, and DMSO, provides formulation flexibility for diverse applications from aqueous serums to lipid-based delivery systems.
Cost performance is optimized through direct manufacturing relationships that eliminate intermediary markups. Bulk buyers benefit from volume discounts that reduce per-milligram costs by up to 60% compared to retail pricing. Additionally, our technical support team provides formulation guidance, stability testing services, and custom packaging options to meet specific buyer requirements. This comprehensive support ensures that buyers receive not just a product, but a complete solution for their peptide sourcing needs.
Q1: What is the minimum purity required for CJC 1295 peptide in cosmetic formulations?
For cosmetic applications, a minimum purity of 98% is recommended to ensure product stability and efficacy. Lower purity grades may contain impurities that cause discoloration, odor, or reduced shelf life in finished formulations. Premium cosmetic brands typically specify 99%+ purity to differentiate their products in the market.
Q2: How should CJC 1295 peptide be stored to maintain its stability during bulk inventory management?
CJC 1295 peptide should be stored as a lyophilized powder at -20°C or below in airtight, light-protected containers. For bulk inventory, divide the material into smaller aliquots to avoid repeated freeze-thaw cycles. Each aliquot should be sealed under argon or nitrogen to prevent oxidation. Under these conditions, the peptide remains stable for at least 24 months.
Q3: What documentation should I request when purchasing CJC 1295 peptide for research purposes?
Request a Certificate of Analysis (CoA) showing HPLC purity with chromatogram, mass spectrometry confirmation, amino acid analysis, endotoxin levels, and residual solvent testing. Also obtain a Material Safety Data Sheet (MSDS), Certificate of Origin, and stability data for your intended storage conditions. For international shipments, confirm that the supplier provides customs documentation and regulatory compliance certificates.